((±))-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butylamine hydrochloride (MBDB)

((±))-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butylamine hydrochloride (MBDB) Basic information
Product Name:((±))-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butylamine hydrochloride (MBDB)
Synonyms:((±))-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butylamine hydrochloride (MBDB);(±)-MBDB HCl;(+\-)-MBDB hydrochloride solution;1-(1,3-benzodioxol-5-yl)-N-methylbutan-2-amine:hydrochloride;N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine Hydrochloride;1-(benzo[d][1,3]dioxol-5-yl)-N-methylbutan-2-amine hydrochloride
CAS:128767-12-4
MF:C12H18ClNO2
MW:243.73
EINECS:
Product Categories:Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:128767-12-4.mol
((±))-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butylamine hydrochloride (MBDB) Structure
((±))-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butylamine hydrochloride (MBDB) Chemical Properties
Fp 9℃
storage temp. 2-8°C
solubility DMF: 10 mg/ml; DMSO: 10 mg/ml; Ethanol: 16 mg/ml; PBS (pH 7.2): 5 mg/ml
form A crystalline solid
Safety Information
Hazard Codes F,T
Risk Statements 11-23/24/25-39/23/24/25
Safety Statements 16-36/37-45
RIDADR UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany 1
MSDS Information
((±))-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butylamine hydrochloride (MBDB) Usage And Synthesis
UsesMBDB ia an analog of MDMA (M303985). MBDB is the N-methylated derivative of BDB (B198900), a hallucinogenic Phenylethylamine derivative. BDB is more potent than MBDB. MBDB is a CNS stimulant.
General DescriptionA certified solution standard suitable for use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis, urine drug testing, or pharmaceutical research. MBDB is an illicit drug structurally related to MDMA, with similar effects including euphoria and mild stimulation.
((±))-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butylamine hydrochloride (MBDB) Preparation Products And Raw materials

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.